Rankings
▼
Calendar
INVA Q4 2023 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$86M
+30.4% YoY
Gross Profit
$73M
84.7% margin
Operating Income
$38M
43.7% margin
Net Income
$62M
71.7% margin
EPS (Diluted)
$0.76
QoQ Revenue Growth
+27.6%
Cash Flow
Operating Cash Flow
$33M
Free Cash Flow
$33M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$569M
Stockholders' Equity
$675M
Cash & Equivalents
$194M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$86M
$66M
+30.4%
Gross Profit
$73M
$53M
+37.2%
Operating Income
$38M
$31M
+21.7%
Net Income
$62M
-$68M
+190.1%
Revenue Segments
Royalty
$66M
77%
Product
$20M
23%
← FY 2023
All Quarters
Q1 2024 →